8-K/A XBRL

FORM 8-K/A

Company: NovaBay Pharmaceuticals, Inc.
Filed: May 31, 2024
Period of Report: March 25, 2024
Accession Number: 0001437749-24-018922

View Document ↗ View on SEC.gov ↗